Navigation Links
Belief, disbelief and uncertainty activate distinct brain regions
Date:12/9/2007

The capacity of the human mind to believe or disbelieve a statement is a powerful force for controlling both behavior and emotion, but the basis of these states in the brain is not yet understood. A new study found that belief, disbelief and uncertainty activate distinct regions of the brain, with belief/disbelief affecting areas associated with the pleasantness/unpleasantness of tastes and odors. The study will publish online in the Annals of Neurology (http://www.interscience.wiley.com/journal/ana), the official journal of the American Neurological Association.

Led by Sam Harris of the University of California, Los Angeles, the study involved 14 adults who underwent functional MRI scans during which they were presented with short statements that they had to evaluate as true, false or undecided. Each participant underwent three scans while they evaluated statements from a broad variety of categories such as mathematical, geographical, autobiographical, religious and factual. The statements were designed to be clearly true, false or undecidable.

Contrasting belief and disbelief trials yielded increased signal in the ventromedial prefrontal cortex (VMPFC), which is involved in linking factual knowledge with emotion. The involvement of the VMPFC in belief processing suggests an anatomical link between the purely cognitive aspects of belief and human emotion and reward, the authors state. The fact that ethical belief showed a similar pattern of activation to mathematical belief suggests that the physiological difference between belief and disbelief is not related to content or emotional associations, they note.

The contrasts between disbelief and belief showed increased signal in the anterior insula, a region involved in the sensation of taste, the perception of pain, and the feeling of disgust, indicating that false propositions might actually disgust us, the authors state. Our results appear to make sense of the emotional tone of disbelief, placing it on a continuum with other modes of stimulus appraisal and rejection, they add.

Uncertainty evoked a positive signal in the anterior cingulate cortext (ACC) and a decreased signal in the caudate, a region of the basal ganglia, which plays a role in motor action. Noting that both belief and disbelief showed an increased signal in the caudate compared to uncertainty, the authors suggest that the basal ganglia may play a role in mediating the cognitive and behavioral differences between decision and indecision.

The study raises the possibility that the differences between belief, disbelief and uncertainty may one day be reliably distinguished by neuroimaging techniques. They conclude: This would have obvious implications for the detection of deception, for the control of the placebo effect during the process of drug design, and for the study of any higher-cognitive phenomenon in which the differences between belief, disbelief, and uncertainty might be a relevant variable.


'/>"/>

Contact: Amy Molnar
amolnar@wiley.com
Wiley-Blackwell
Source:Eurekalert

Related medicine news :

1. Activate America(R) Brings Together YMCAs Nationwide to Promote Small Steps Toward a Healthier Lifestyle During America on the Move Week With the YMCA, September 22-29, 2007
2. YMCAs Activate America(R) Motivates More Than 1.3 Million People to Take 8 Billion Steps Toward a Healthier Lifestyle During America On the Move Week with the YMCA
3. Mayo Clinic Multidisciplinary Simulation Center Receives Distinction as an ACS-Accredited Education Institute
4. J.D. Power and Associates Reports: Hackensack University Medical Center Recognized as First Hospital to Achieve Distinction for Providing an Outstanding Inpatient Experience in All Four Service Areas
5. Gene screen patent leads to Deal of Distinction
6. Distinctive Art Auction Supports American Red Cross of Central New Jersey
7. Draining away brains toxic protein to stop Alzheimers
8. Vision restoration therapy shown to improve brain activity in brain injured patients
9. Clinical depression linked to abnormal emotional brain circuits
10. Brain imaging reveals breakdown of normal emotional processing
11. Brain cells work differently than previously thought
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... , ... September 25, 2017 , ... Bobbie Horowitz was ... Osteoarthritis and multiple health issues. As a cabaret and theater producer, Horowitz would manage ... main source of transportation in New York City, so she had to take a ...
(Date:9/25/2017)... ... September 25, 2017 , ... Physician Partners of America ... at 5304 Main Street as an interventional pain management specialist. , Dr. Gorman ... He joins PPOA from private practice In Brooksville, Fla. His orthopedic background puts him ...
(Date:9/25/2017)... Charles, LA (PRWEB) , ... September 25, 2017 , ... ... in Lake Charles, LA. “I could not imagine doing anything else,” said Dr. Hebert. ... me each and every day. The interactions with my patients is what I look ...
(Date:9/25/2017)... ... September 25, 2017 , ... “The Majestic Unicorn”: a poignant ... “The Majestic Unicorn” is the creation of published author, Dayna Chantel, an artist and ... far and wide to march aboard the cypress ark-vessel. Male and female, no matter ...
(Date:9/25/2017)... VA (PRWEB) , ... September 25, 2017 , ... ... and Response Preconference Workshop, **Presented by FDAnews**, Nov. 1-3, 2017 – Bethesda, MD, ... drugmaker passed with flying colors. And then, on the tenth inspection it failed. ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... MOUNTAIN LAKES, N.J. , Sept. 12, 2017  Consumer reviews ... Embrace Hearing as the number one company for hearing ... Oticon™, ReSound™ and fifteen other brands. ... Embrace Hearing Named #1 by Consumers For Hearing Aids ... Embrace Hearing is an online store that ...
(Date:9/9/2017)... INDIANAPOLIS , Sept. 9, 2017  Eli Lilly ... key primary and secondary endpoint data for lasmiditan, an ... migraine, which demonstrated statistically significant improvements compared to placebo ... be highlighted today at the 18th Congress of the ... . "The data presented today demonstrate lasmiditan,s ...
(Date:9/7/2017)... STOCKHOLM , Sept. 7, 2017 NuvoAir ... Air Smart Spirometer, announced today a partnership with Novartis Pharma ... partnership solidifies NuvoAir,s position as the leading mobile spirometry platform ... respiratory patients. ... spirometry test ...
Breaking Medicine Technology: